Chemomab Therapeutics Ltd. (CMMB) News
Track canonical SquawkNews coverage tagged to CMMB, Chemomab Therapeutics Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Top Midday Decliners
() -- Chemomab Therapeutics (CMMB) and Scipher Medicine have entered into an all-stock merger agreement, the companies said Wednesday. Shares of Chemomab dropped 14% as intraday trading volume jumped to over 1.79 million
MNA | Jul 08, 2026, 06:07 PM UTC
H
Chemomab Therapeutics, Scipher Medicine to Merge in All-Stock Deal
() -- Chemomab Therapeutics (CMMB) and Scipher Medicine have entered into an all-stock merger agreement, the companies said Wednesday. Under the terms of the merger, Chemomab equity holders are expected to own around 32%
MNA | Jul 08, 2026, 12:17 PM UTC
L
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Curis (NASDAQ: CRIS ) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million. Humacyte (NASDAQ: HUMA ) shares moved upwards by 5.45% to $0.71. The marke
EQUITY | Jul 01, 2026, 09:05 PM UTC